Comparative Efficacy of Lipid-Based Versus Polymer-Based Vectors for Mouse Transfection

Efficient transfection of mouse tissues in vivo requires delivery systems that can overcome extracellular and intracellular barriers while maintaining biocompatibility and gene modulation capability. Lipid-based and polymer-based vectors represent two of the most commonly used non-viral systems for delivering nucleic acids in mouse models, each offering unique advantages and limitations that influence their applicability depending on the tissue type, payload, and route of administration.

Lipid-based vectors, such as cationic liposomes and lipid nanoparticles (LNPs), function by forming electrostatic complexes with negatively charged nucleic acids. These complexes facilitate cellular uptake primarily through endocytosis. Once inside the endosomal compartment, ionizable lipids become protonated in the acidic environment, triggering membrane fusion and cytoplasmic release of the nucleic acid. Lipid formulations are typically composed of helper lipids (e.g., DOPE or cholesterol) and stabilizing agents like polyethylene glycol (PEG), which improves colloidal stability and prolongs circulation half-life. Lipid vectors are widely used in mouse liver transfection due to their high hepatic tropism following systemic administration. Furthermore, lipid particles can be functionalized with tissue-targeting ligands, such as GalNAc for hepatocytes or transferrin for tumor tissue, enabling selective delivery and minimizing off-target accumulation.

In contrast, polymer-based vectors rely on synthetic or naturally derived polymers, including polyethyleneimine (PEI), chitosan, and dendrimers, to condense nucleic acids into nanoparticles. These polyplexes protect nucleic acids from enzymatic degradation and enhance cellular uptake. PEI, for instance, has been extensively studied due to its high cationic charge density and capacity for endosomal escape via the proton sponge effect. However, this same property contributes to dose-limiting cytotoxicity and inflammatory responses, particularly in sensitive tissues. Modifications such as PEGylation, pH-responsive side chains, or co-formulation with biodegradable materials are often employed to mitigate these issues and improve transfection performance. Compared to lipid systems, polymeric carriers generally offer greater formulation versatility and cargo compatibility, including for larger DNA constructs or protein-nucleic acid complexes.

Performance metrics between lipid and polymer-based vectors vary significantly depending on experimental conditions. For example, in lung transfection models using intranasal delivery, polymeric nanoparticles can exhibit deeper tissue penetration and prolonged retention relative to liposomes. Conversely, for systemic siRNA delivery targeting hepatic or tumor tissues, LNPs demonstrate superior knockdown efficiency and reproducibility. The nature of the payload also influences vector choice—lipid systems are especially efficient for RNA delivery, while polymers may be better suited for stable DNA transfection or applications requiring controlled release kinetics.

Mouse strain and immune status must also be considered. In immunocompetent strains, both lipid and polymeric formulations can trigger innate immune responses via pattern recognition receptors such as TLRs, leading to cytokine release and reduced efficacy. Use of immunodeficient strains, such as NSG or NOD/SCID, can reduce variability and improve transfection consistency. Chemical modifications to the nucleic acid backbone, such as 2′-O-methylation or phosphorothioate linkage, are often incorporated to further suppress immune activation and increase stability.

Overall, both lipid- and polymer-based vectors play a vital role in the advancement of in vivo gene delivery methods in mouse models. Lipids offer high transfection efficiency and well-characterized pharmacokinetics, while polymers bring flexibility in design and tunable biophysical properties. The selection of an optimal vector requires balancing transfection efficiency, cytotoxicity, tissue specificity, and immune compatibility, all of which must be carefully tailored to the specific objectives of each mouse-based research study.